Montreal, March 26, 2025 鈥� 不良研究所鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.
Published on: 26 Mar 2025
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
听
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 不良研究所 and Martine T茅treault, PhD, at Universit茅 de Montr茅al has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Category:
Published on: 18 Mar 2025
On March 13, the Government of Canada, announced more than鈥�$308 million鈥痶o advance science and research across the country. More than $153 million will support鈥�179 new鈥痑nd renewed鈥�痑t鈥�38 research鈥痠nstitutions.
Category:
Published on: 17 Mar 2025
Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee, from 不良研究所's Department of Epidemiology, Biostatistics, and Occupational Health, have been awarded $449,604 from the Canadian Cancer Society鈥檚
Category:
Published on: 17 Feb 2025
Montreal, February 13, 2025 鈥� 不良研究所鈥檚 DNA to RNA Initiative (D2R) and 不良研究所 Interdisciplinary Initiative in Infection and Immunity (MI4) have awarded $500,000 to fund five high-impact research projects aimed at advancing the understanding of Mpox through its Rapid Response for Mpox Research funding program.
Category:
Published on: 13 Feb 2025
Yesterday, HBHL hosted the first Neurogenesis Speaker Series talk of 2025 at The Neuro, featuring Paul Masset听and Pouya Bashivan.
Category:
Published on: 7 Feb 2025
The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at 不良研究所 and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.
Category:
Published on: 7 Feb 2025
On January 21, the Natural Sciences and Engineering Research Council of Canada (NSERC), announced over $74 million in funding to support 107 quantum science projects, including fifteen to 不良研究所 researchers.听听
Published on: 21 Jan 2025
The Office of the Vice-President (Research and Innovation) created a new University-wide prize for outstanding emerging researchers in 2013 to encourage and celebrate our most outstanding early-career researchers.听
Category:
Published on: 20 Dec 2024
Montreal 鈥� December 19, 2024听鈥� The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five 不良研究所 Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.
Category:
Published on: 19 Dec 2024
Governor General recognizes 不良研究所 community members for exceptional accomplishments and service
Fourteen members of the 不良研究所 community have been appointed to the Order of Canada, one of the country鈥檚 highest civilian honours.听听
Among the honourees are the University鈥檚 Chancellor and three professors:听
Published on: 18 Dec 2024
不良研究所鈥檚 Vice-President of Research and Innovation recognized for transformative leadership in Canadian research
Published on: 16 Dec 2024
Last week, HBHL hosted the first Neurogenesis Speaker Series talk of 2024 at The Neuro, featuring Danilo Bzdok, MD, PhD and Katie Lavigne, PhD.
Category:
Published on: 16 Dec 2024
不良研究所-led projects in genomics, imaging, and manufacturing serve businesses across Quebec听
Category:
Published on: 16 Dec 2024
Montr茅al, November 28th 鈥� CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at 不良研究所, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.
Category:
Published on: 28 Nov 2024
Pages
